JPY 796.0
(0.63%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 2.04 Billion JPY | -0.73% |
2022 | 2.05 Billion JPY | 226.31% |
2021 | 631 Million JPY | -78.58% |
2020 | 2.94 Billion JPY | 31.52% |
2019 | 2.24 Billion JPY | 10.07% |
2018 | 2.03 Billion JPY | -13.18% |
2017 | 2.34 Billion JPY | 80.59% |
2016 | 1.29 Billion JPY | 113.14% |
2015 | 609 Million JPY | 395.63% |
2014 | -206 Million JPY | -121.37% |
2013 | 964 Million JPY | 37.32% |
2012 | 702 Million JPY | 7.83% |
2011 | 651 Million JPY | -41.09% |
2010 | 1.1 Billion JPY | 70.79% |
2009 | 647 Million JPY | 78.24% |
2008 | 363 Million JPY | 67.73% |
2007 | 216.42 Million JPY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 288 Million JPY | -64.09% |
2023 Q3 | 225 Million JPY | -75.94% |
2023 FY | 2.04 Billion JPY | -0.73% |
2023 Q1 | 246 Million JPY | -69.17% |
2023 Q2 | 935 Million JPY | 280.08% |
2023 Q4 | 802 Million JPY | 256.44% |
2022 Q1 | 241 Million JPY | 3916.67% |
2022 FY | 2.05 Billion JPY | 226.31% |
2022 Q4 | 798 Million JPY | 46.42% |
2022 Q3 | 545 Million JPY | 14.74% |
2022 Q2 | 475 Million JPY | 97.1% |
2021 Q4 | 6 Million JPY | -83.78% |
2021 Q2 | 456 Million JPY | 245.45% |
2021 Q3 | 37 Million JPY | -91.89% |
2021 Q1 | 132 Million JPY | 500.0% |
2021 FY | 631 Million JPY | -78.58% |
2020 FY | 2.94 Billion JPY | 31.52% |
2020 Q3 | 816 Million JPY | -42.94% |
2020 Q2 | 1.43 Billion JPY | 65.89% |
2020 Q1 | 862 Million JPY | -2.49% |
2020 Q4 | -33 Million JPY | -104.04% |
2019 Q4 | 884 Million JPY | 151.85% |
2019 Q2 | 859 Million JPY | 488.36% |
2019 FY | 2.24 Billion JPY | 10.07% |
2019 Q1 | 146 Million JPY | -74.25% |
2019 Q3 | 351 Million JPY | -59.14% |
2018 FY | 2.03 Billion JPY | -13.18% |
2018 Q3 | 450 Million JPY | -45.45% |
2018 Q1 | 193 Million JPY | -78.53% |
2018 Q4 | 567 Million JPY | 26.0% |
2018 Q2 | 825 Million JPY | 327.46% |
2017 Q1 | 136 Million JPY | -65.04% |
2017 Q2 | 880 Million JPY | 547.06% |
2017 FY | 2.34 Billion JPY | 80.59% |
2017 Q3 | 429 Million JPY | -51.25% |
2017 Q4 | 899 Million JPY | 109.56% |
2016 Q2 | 400 Million JPY | 1233.33% |
2016 FY | 1.29 Billion JPY | 113.14% |
2016 Q4 | 389 Million JPY | -18.79% |
2016 Q3 | 479 Million JPY | 19.75% |
2016 Q1 | 30 Million JPY | -91.87% |
2015 Q1 | -269 Million JPY | -6825.0% |
2015 FY | 609 Million JPY | 395.63% |
2015 Q4 | 369 Million JPY | 0.0% |
2014 Q4 | 4 Million JPY | 101.81% |
2014 FY | -206 Million JPY | -121.37% |
2014 Q3 | -221 Million JPY | -172.22% |
2014 Q2 | 306 Million JPY | 203.73% |
2014 Q1 | -295 Million JPY | -186.01% |
2013 Q2 | 369 Million JPY | 747.37% |
2013 Q3 | 309 Million JPY | -16.26% |
2013 Q4 | 343 Million JPY | 11.0% |
2013 FY | 964 Million JPY | 37.32% |
2013 Q1 | -57 Million JPY | -122.01% |
2012 Q3 | 374 Million JPY | 910.81% |
2012 Q4 | 259 Million JPY | -30.75% |
2012 Q2 | 37 Million JPY | 15.63% |
2012 FY | 702 Million JPY | 7.83% |
2012 Q1 | 32 Million JPY | -33.33% |
2011 Q2 | 282 Million JPY | 200.0% |
2011 FY | 651 Million JPY | -41.09% |
2011 Q1 | 94 Million JPY | 1780.0% |
2011 Q3 | 227 Million JPY | -19.5% |
2011 Q4 | 48 Million JPY | -78.85% |
2010 Q4 | 5 Million JPY | -98.58% |
2010 FY | 1.1 Billion JPY | 70.79% |
2010 Q3 | 352 Million JPY | 1.15% |
2010 Q2 | 348 Million JPY | 2.05% |
2010 Q1 | 341 Million JPY | 163.5% |
2009 Q3 | 528 Million JPY | 242.86% |
2009 Q4 | -537 Million JPY | -201.7% |
2009 Q1 | 501 Million JPY | 803.08% |
2009 FY | 647 Million JPY | 78.24% |
2009 Q2 | 154 Million JPY | -69.26% |
2008 Q2 | 122 Million JPY | 0.0% |
2008 Q3 | 163 Million JPY | 33.61% |
2008 Q4 | 55.47 Million JPY | -65.97% |
2008 FY | 363 Million JPY | 67.73% |
2007 FY | 216.42 Million JPY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
HEARTSEED INC | -1.45 Billion JPY | 240.037% |
Cawachi Limited | 7.6 Billion JPY | 73.109% |
Pharmarise Holdings Corporation | 916 Million JPY | -123.144% |
Qol Holdings Co., Ltd. | 8.32 Billion JPY | 75.447% |
MatsukiyoCocokara & Co. | 75.7 Billion JPY | 97.3% |
Welcia Holdings Co., Ltd. | 43.23 Billion JPY | 95.272% |
Create SD Holdings Co., Ltd. | 20.22 Billion JPY | 89.895% |
NIHON CHOUZAI Co.,Ltd. | 9.14 Billion JPY | 77.647% |
COSMOS Pharmaceutical Corporation | 31.5 Billion JPY | 93.511% |
Tsuruha Holdings Inc. | 49.2 Billion JPY | 95.846% |
Satudora Holdings Co.,Ltd. | 1.38 Billion JPY | -47.581% |
Kusuri No Aoki Holdings Co., Ltd. | 18.56 Billion JPY | 88.992% |
Medical System Network Co., Ltd. | 3.83 Billion JPY | 46.66% |
Shinnihonseiyaku Co., Ltd. | 3.75 Billion JPY | 45.551% |
Sugi Holdings Co.,Ltd. | 36.62 Billion JPY | 94.419% |
YAKUODO HOLDINGS Co., Ltd. | 5.21 Billion JPY | 60.775% |
Astena Holdings Co., Ltd. | 1.12 Billion JPY | -81.191% |
Genky DrugStores Co., Ltd. | 9.01 Billion JPY | 77.329% |
Ain Holdings Inc. | 20.43 Billion JPY | 89.996% |
Sundrug Co.,Ltd. | 40.99 Billion JPY | 95.014% |